Literature DB >> 3584358

High-performance liquid chromatographic determination of diltiazem and its major metabolites, N-monodemethyldiltiazem and desacetyldiltiazem, in plasma.

S C Montamat, D R Abernethy, J R Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3584358     DOI： 10.1016/s0378-4347(00)83211-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

Review 1.  Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

Authors:  M M Buckley; S M Grant; K L Goa; D McTavish; E M Sorkin
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Bioinequivalence of marketed diltiazem preparations.

Authors:  M V Joshi; P C Gokhale; S M Pohujani; S S Dalvi; S M Karandikar; N A Kshirsagar
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives.

Authors:  S C Montamat; D R Abernethy
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

4.  Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure.

Authors:  Y H Lee; M H Lee; C K Shim
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.